Oxford Vaccine Group Andrew Pollard
- All
- News
-
Herd Immunity Not A Possibility With Delta Variant, Warns UK Vaccine Expert
The highly transmissible Delta variant of coronavirus has rendered the prospect of herd immunity, where the majority of a country's population becomes immune to a virus, difficult, the head of the UK's Oxford Vaccine Group has warned.
-
Growing Evidence On Oxford Shot Should Guide Other Countries, Vaccine Chief Says
Real-world data on the effectiveness of Oxford and AstraZeneca's COVID-19 vaccine in older people from its rollout in Britain should help inform decision making in other countries, Oxford Vaccine Group Director Andrew Pollard said on Tuesday.
-
Covid Vaccines May Provide Protection Even As Variants Evolve: Oxford
COVID-19 vaccines might offer protection against severe disease even as coronavirus variants evolve to better allow continued transmission between people, the head of the Oxford Vaccine Group Andrew Pollard said on Wednesday.
-
Herd Immunity Not A Possibility With Delta Variant, Warns UK Vaccine Expert
The highly transmissible Delta variant of coronavirus has rendered the prospect of herd immunity, where the majority of a country's population becomes immune to a virus, difficult, the head of the UK's Oxford Vaccine Group has warned.
-
Growing Evidence On Oxford Shot Should Guide Other Countries, Vaccine Chief Says
Real-world data on the effectiveness of Oxford and AstraZeneca's COVID-19 vaccine in older people from its rollout in Britain should help inform decision making in other countries, Oxford Vaccine Group Director Andrew Pollard said on Tuesday.
-
Covid Vaccines May Provide Protection Even As Variants Evolve: Oxford
COVID-19 vaccines might offer protection against severe disease even as coronavirus variants evolve to better allow continued transmission between people, the head of the Oxford Vaccine Group Andrew Pollard said on Wednesday.
